Clinical Trials Directory

Trials / Unknown

UnknownNCT05894642

Characterization of Long Covid Pain in Primary Care

Determination and Characterization of Persistent Musculoskeletal Pain in Covid-19 Patients in Primary Care.

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University of Valladolid · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Justification: among the sequelae of Covid-19 in clinical practice we frequently find persistent neuromusculoskeletal pain. Prevalence data and the underlying mechanisms of such pain are very limited in the scientific literature. Therefore, with this research we will try to answer these questions. Main objective: to determine and characterize persistent musculoskeletal pain in Covid-19 patients. Method: two phases. First, a descriptive cross-sectional study will be carried out to estimate the prevalence of Long Covid Pain (LCP). Second phase, a case-control study will be carried out using the sample obtained in the first phase as the population. The sample will be divided into two groups: post-Covid-19 patients with LCP and post-Covid-19 patients without persistent pain (control group). The two groups will be matched according to sex, age and level of severity of the pathology. An assessment and comparison between groups will be made of the following variables: central sensitization, healthy physical condition and blood test values, which will be evaluated by means of physical examination, questionnaires and laboratory tests. Applicability of the results: this is a pioneering project at the national level, which would determine more reliably the prevalence of LCP in postcovid and could be a first step in the search for the best therapeutic strategies for these patients. This would help to improve the quality of life of these patients and to better manage the social and healthcare resources used in their treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL0It is a case-control study, cross-sectional, so there is no intervention possible.

Timeline

Start date
2022-05-15
Primary completion
2023-12-01
Completion
2024-02-01
First posted
2023-06-08
Last updated
2023-06-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05894642. Inclusion in this directory is not an endorsement.